Bradley Foster & Sargent’s Vaxart VXRT Stock Holding History

Bradley Foster & Sargent’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$101K	–	471
2022 Q1	$101K	Hold	20,000	–	–	﹤0.01%	463
2021 Q4	$125K	Hold	20,000	–	–	﹤0.01%	439
2021 Q3	$159K	Hold	20,000	–	–	﹤0.01%	406
2021 Q2	$150K	Hold	20,000	–	–	﹤0.01%	394
2021 Q1	$121K	Buy	+20,000	New	+$154K	﹤0.01%	374

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bradley Foster & Sargent's VXRT Position: Q2 2022 in Review

Bradley Foster & Sargent sold out of Vaxart (VXRT) in Q2 2022, closing a stake of 20,000 shares — an estimated $101K sold.

Bradley Foster & Sargent first reported a position in VXRT in Q1 2021 and held it in 5 quarters. The position peaked at $159K in Q3 2021. 146 funds tracked by Wall St. Rank hold VXRT as of Q2 2022.

Bradley Foster & Sargent reported no remaining Vaxart position as of Q2 2022 after selling out during the quarter.
Bradley Foster & Sargent sold 20,000 Vaxart shares in Q2 2022, an estimated $101K.
Bradley Foster & Sargent first reported a position in Vaxart in Q1 2021 and held it in 5 quarters.
Bradley Foster & Sargent's Vaxart position peaked at $159K in Q3 2021.
146 funds tracked by Wall St. Rank held Vaxart as of Q2 2022.

Based on Bradley Foster & Sargent's 13F filing for Q2 2022, filed 11 Aug 2022.